| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
21,942 |
20,317 |
$1.55M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
6,326 |
6,120 |
$643K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
12,318 |
12,306 |
$575K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
5,853 |
5,853 |
$544K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
4,744 |
4,560 |
$412K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
1,483 |
1,461 |
$206K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
984 |
983 |
$91K |
| 87428 |
|
1,934 |
1,895 |
$56K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
5,462 |
4,631 |
$48K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
453 |
450 |
$38K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
2,451 |
2,408 |
$35K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
927 |
918 |
$30K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
1,261 |
1,260 |
$23K |
| 96161 |
|
2,186 |
2,143 |
$11K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
337 |
329 |
$9K |
| 96127 |
|
1,386 |
1,382 |
$5K |
| 0071A |
|
113 |
113 |
$5K |
| 0072A |
|
108 |
108 |
$4K |
| 87807 |
|
349 |
341 |
$4K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
28 |
28 |
$3K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
46 |
44 |
$2K |
| 83655 |
|
181 |
180 |
$2K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
96 |
94 |
$2K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
12 |
12 |
$2K |
| 99383 |
|
13 |
13 |
$1K |
| 90480 |
|
29 |
29 |
$1K |
| 99460 |
|
13 |
13 |
$1K |
| 54150 |
|
12 |
12 |
$1K |
| 85018 |
|
194 |
194 |
$425.60 |
| 99173 |
|
66 |
66 |
$168.32 |
| 90686 |
|
3,009 |
3,009 |
$78.14 |
| 90656 |
|
275 |
275 |
$0.03 |
| 90677 |
|
462 |
462 |
$0.02 |
| 90716 |
|
315 |
315 |
$0.00 |
| 90647 |
|
1,521 |
1,521 |
$0.00 |
| 90723 |
|
1,742 |
1,741 |
$0.00 |
| 90680 |
|
1,366 |
1,366 |
$0.00 |
| 91307 |
|
246 |
230 |
$0.00 |
| 90696 |
|
13 |
13 |
$0.00 |
| 90670 |
|
2,804 |
2,804 |
$0.00 |
| 90707 |
|
251 |
251 |
$0.00 |
| 90633 |
|
184 |
184 |
$0.00 |
| 90672 |
|
24 |
24 |
$0.00 |
| 91308 |
|
27 |
25 |
$0.00 |
| 90671 |
|
14 |
14 |
$0.00 |
| 96160 |
|
15 |
15 |
$0.00 |